St. James's Place Valuation
Is STJP.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of STJP.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: STJP.F ($9.48) is trading below our estimate of fair value ($18.01)
Significantly Below Fair Value: STJP.F is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for STJP.F?
Key metric: As STJP.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is STJP.F's PS Ratio? | |
|---|---|
| PS Ratio | 0.2x |
| Sales | UK£26.80b |
| Market Cap | UK£4.62b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.2x |
| Enterprise Value/EBITDA | 8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does STJP.F's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 8.9x | ||
MAIN Main Street Capital | 9.1x | 4.7% | US$4.8b |
AMG Affiliated Managers Group | 2.8x | 5.5% | US$5.7b |
HLNE Hamilton Lane | 12.8x | 10.3% | US$8.4b |
CNS Cohen & Steers | 10.8x | 9.3% | US$5.3b |
STJP.F St. James's Place | 0.2x | -98.6% | US$4.6b |
Price-To-Sales vs Peers: STJP.F is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (8.9x).
Price to Sales Ratio vs Industry
How does STJP.F's PS Ratio compare vs other companies in the US Capital Markets Industry?
| 25 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| Industry Avg. | 3.4x | 5.2% | |
STJP.F St. James's Place | 0.2x | -98.6% | US$5.80b |
SNEX StoneX Group | 0.03x | n/a | US$3.34b |
OPY Oppenheimer Holdings | 0.5x | n/a | US$628.67m |
| 25 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
| Industry Avg. | 3.4x | 11.4% | |
STJP.F St. James's Place | 0.2x | 27.3% | US$5.80b |
Price-To-Sales vs Industry: STJP.F is good value based on its Price-To-Sales Ratio (0.2x) compared to the US Capital Markets industry average (3.4x).
Price to Sales Ratio vs Fair Ratio
What is STJP.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.2x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate STJP.F's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$9.48 | US$11.30 +19.2% | 18.9% | US$17.59 | US$8.67 | n/a | 14 |
| Nov ’25 | n/a | US$11.66 0% | 19.1% | US$18.21 | US$8.97 | n/a | 14 |
| Oct ’25 | US$10.20 | US$11.25 +10.3% | 20.7% | US$18.59 | US$8.77 | n/a | 14 |
| Sep ’25 | US$9.48 | US$10.95 +15.5% | 22.1% | US$18.43 | US$8.16 | n/a | 14 |
| Aug ’25 | US$8.76 | US$10.43 +19.1% | 24.8% | US$18.00 | US$6.75 | n/a | 15 |
| Jul ’25 | n/a | US$9.11 0% | 32.1% | US$17.70 | US$5.69 | n/a | 15 |
| Jun ’25 | n/a | US$8.87 0% | 34.2% | US$17.57 | US$5.65 | n/a | 14 |
| May ’25 | n/a | US$8.97 0% | 33.0% | US$17.49 | US$6.25 | n/a | 14 |
| Apr ’25 | n/a | US$9.09 0% | 32.8% | US$17.69 | US$6.32 | n/a | 14 |
| Mar ’25 | US$6.43 | US$10.08 +56.8% | 28.6% | US$17.72 | US$6.33 | n/a | 14 |
| Feb ’25 | US$8.54 | US$11.60 +35.9% | 19.6% | US$17.79 | US$8.30 | n/a | 15 |
| Jan ’25 | n/a | US$12.63 0% | 32.6% | US$22.81 | US$8.37 | n/a | 15 |
| Dec ’24 | US$8.01 | US$12.15 +51.7% | 32.7% | US$21.98 | US$8.06 | n/a | 15 |
| Nov ’24 | US$7.85 | US$12.31 +56.8% | 32.6% | US$21.82 | US$8.00 | n/a | 15 |
| Oct ’24 | US$10.16 | US$15.92 +56.8% | 17.8% | US$24.38 | US$12.38 | US$10.20 | 16 |
| Sep ’24 | US$10.66 | US$16.17 +51.7% | 17.8% | US$24.70 | US$12.54 | US$9.48 | 16 |
| Aug ’24 | n/a | US$16.93 0% | 16.7% | US$25.03 | US$12.71 | US$8.76 | 16 |
| Jul ’24 | US$13.42 | US$18.47 +37.7% | 12.6% | US$24.91 | US$14.81 | n/a | 17 |
| Jun ’24 | US$14.08 | US$17.76 +26.1% | 12.6% | US$24.02 | US$14.28 | n/a | 17 |
| May ’24 | US$14.46 | US$17.99 +24.4% | 12.5% | US$24.36 | US$14.48 | n/a | 16 |
| Apr ’24 | n/a | US$17.89 0% | 12.1% | US$23.96 | US$14.75 | n/a | 16 |
| Mar ’24 | n/a | US$17.26 0% | 13.4% | US$23.44 | US$13.86 | US$6.43 | 16 |
| Feb ’24 | n/a | US$17.29 0% | 14.4% | US$24.08 | US$14.24 | US$8.54 | 16 |
| Jan ’24 | US$13.14 | US$17.07 +29.8% | 16.0% | US$24.23 | US$12.67 | n/a | 17 |
| Dec ’23 | US$13.91 | US$16.24 +16.8% | 15.5% | US$23.19 | US$12.13 | US$8.01 | 17 |
| Nov ’23 | n/a | US$16.10 0% | 16.5% | US$22.67 | US$11.86 | US$7.85 | 16 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Qifu Technology
US$5.4b
Operates credit-tech platform under the 360 Jietiao brand in the People’s Republic of China.
QFIN
US$33.85
7D
4.9%
1Y
115.6%
Guild Holdings
US$844.7m
Guild Holdings Company originates, sells, and services residential mortgage loans in the United States.
GHLD
US$13.79
7D
-1.4%
1Y
12.6%
FinVolution Group
US$1.6b
Operates in the online consumer finance industry.
FINV
US$6.24
7D
3.5%
1Y
40.2%